Abbott Labs Q3 Profit Surges, but Revenues Slip
Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in expenses. The health care company posted adjusted earnings per share (EPS) of…